These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11784154)

  • 41. Inhibition of human carbonic anhydrase isozymes I, II, IX and XII with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties.
    Alafeefy AM; Abdel-Aziz HA; Vullo D; Al-Tamimi AM; Awaad AS; Mohamed MA; Capasso C; Supuran CT
    J Enzyme Inhib Med Chem; 2015 Feb; 30(1):52-6. PubMed ID: 24666294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V and IX with complex fluorides, chlorides and cyanides.
    Innocenti A; Antel J; Wurl M; Vullo D; Firnges MA; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1909-13. PubMed ID: 15780631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV.
    Smaine FZ; Pacchiano F; Rami M; Barragan-Montero V; Vullo D; Scozzafava A; Winum JY; Supuran CT
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6332-5. PubMed ID: 18990571
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The human carbonic anhydrase isoenzymes I and II (hCA I and II) inhibition effects of trimethoxyindane derivatives.
    Taslimi P; Gulcin I; Ozgeris B; Goksu S; Tumer F; Alwasel SH; Supuran CT
    J Enzyme Inhib Med Chem; 2016; 31(1):152-7. PubMed ID: 25697270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carbonic anhydrase inhibitors: synthesis of water soluble sulfonamides incorporating a 4-sulfamoylphenylmethylthiourea scaffold, with potent intraocular pressure lowering properties.
    Casini A; Scozzafava A; Mincione F; Menabuoni L; Supuran CT
    J Enzyme Inhib Med Chem; 2002 Oct; 17(5):333-43. PubMed ID: 12683750
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate.
    Innocenti A; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Feb; 15(3):567-71. PubMed ID: 15664814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors.
    Yaseen R; Ekinci D; Senturk M; Hameed AD; Ovais S; Rathore P; Samim M; Javed K; Supuran CT
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1337-41. PubMed ID: 26804228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.
    Carta F; Garaj V; Maresca A; Wagner J; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT
    Bioorg Med Chem; 2011 May; 19(10):3105-19. PubMed ID: 21515057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mono-/dihydroxybenzoic acid esters and phenol pyridinium derivatives as inhibitors of the mammalian carbonic anhydrase isoforms I, II, VII, IX, XII and XIV.
    Carta F; Vullo D; Maresca A; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2013 Mar; 21(6):1564-9. PubMed ID: 22668600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates.
    Innocenti A; Vullo D; Scozzafava A; Casey JR; Supuran C
    Bioorg Med Chem Lett; 2005 Feb; 15(3):573-8. PubMed ID: 15664815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors.
    Kumar R; Vats L; Bua S; Supuran CT; Sharma PK
    Eur J Med Chem; 2018 Jul; 155():545-551. PubMed ID: 29909339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
    Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
    Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and carbonic anhydrase inhibitory effects of new N-glycosylsulfonamides incorporating the phenol moiety.
    Riafrecha LE; Bua S; Supuran CT; Colinas PA
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3892-5. PubMed ID: 27423482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4- and 3-nitrophthalimide moieties.
    Sethi KK; Verma SM; Tanç M; Purper G; Calafato G; Carta F; Supuran CT
    Bioorg Med Chem; 2014 Mar; 22(5):1586-95. PubMed ID: 24513184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme.
    Temperini C; Scozzafava A; Vullo D; Supuran CT
    Chemistry; 2006 Sep; 12(27):7057-66. PubMed ID: 16807956
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis, cytotoxicity and carbonic anhydrase inhibitory activities of new pyrazolines.
    Kucukoglu K; Oral F; Aydin T; Yamali C; Algul O; Sakagami H; Gulcin I; Supuran CT; Gul HI
    J Enzyme Inhib Med Chem; 2016; 31(sup4):20-24. PubMed ID: 27579806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of the α-carbonic anhydrase from Vibrio cholerae with amides and sulfonamides incorporating imidazole moieties.
    De Vita D; Angeli A; Pandolfi F; Bortolami M; Costi R; Di Santo R; Suffredini E; Ceruso M; Del Prete S; Capasso C; Scipione L; Supuran CT
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):798-804. PubMed ID: 28569564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties.
    Masereel B; Rolin S; Abbate F; Scozzafava A; Supuran CT
    J Med Chem; 2002 Jan; 45(2):312-20. PubMed ID: 11784136
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity.
    de Leval X; Ilies M; Casini A; Dogné JM; Scozzafava A; Masini E; Mincione F; Starnotti M; Supuran CT
    J Med Chem; 2004 May; 47(11):2796-804. PubMed ID: 15139757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.